3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Rectal Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Muscle Weakness
1
Health Status Unknown
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
pembrolizumab
2
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Specimen Handling
1
Photons
1
Oxaliplatin
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Gemcitabine
1
Disulfides
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.